Molydyn Wins £25k Prize for Innovation

QantX have awarded Matthew Bone, CEO of Molydyn, a £25,000 Blavatnik Prize for Innovation to support commercial trials of his newly released Atlas platform.

Computational tools have shown extreme benefit for biological sciences and drug development. However, material science as a sector has low uptake of chemical modelling approaches due to a skills gap, with the complexity, cost, and growth of AI in biology capturing experienced computational scientists and funding.

Molydyn is supporting material scientists, democratising access to powerful tools with the potential to significantly reduce wasted time and resources by reducing the number of experiments required. With the launch of Atlas in September 2022, we’re simplifying the use of LAMMPS, an open-source molecular dynamics simulator, to help materials scientists get started and accelerate their simulations.

Richard Haycock, CEO QantX, said: "There is on-going need for new materials discovery in relation to many aspects of industry, perhaps most pressingly in relation to new ways of dealing with the climate emergency. However, discovery cycles in this industry are slow and cumbersome.

“Matthew Bone of Molydyn has impressed us with his vision of solving this problem with the use of modern digital tools. The Blavatnik Prize for Innovation is pleased to support their initiative in bringing these tools to market and ultimately helping to solve significant global challenges."

Matthew Bone, Molydyn CEO, said: "The Blavatnik prize will really help Molydyn to develop the next stage of our simulation technology, as we optimise our tools for commercial grade materials. We're thankful to QantX for their support, and look forward to working with them to help drive sustainable materials discovery."